Japanese scientists have found a way to treat congenital deafness

Japanese researchers have made a major breakthrough in solving the problem of hereditary hearing loss. They have developed a new gene therapy method to correct a mutation in the GJB2 gene, one of the main causes of congenital deafness.

The GJB2 gene and its importance

The GJB2 gene plays an important role in transmitting sound signals to cells in the inner ear. It is responsible for producing special proteins that participate in the process of receiving and processing sound signals in the body. However, some mutations in this gene disrupt this process, causing a person to become congenitally deaf.

New gene therapy method

Scientists have found a way to solve this problem using gene editing technology. They found that the problem can be solved by delivering a properly functioning GJB2 gene to ear cells using a harmless virus.

Since conventional methods for gene editing are designed to transfer large amounts of information, scientists have developed a compact and precise version of this process.

Laboratory tests and results

The new method was tested on human cells and laboratory mice. As a result, gene therapy restored the function of ear cells to the same level as in a healthy body. This opens up the possibility of effective treatment for people who are congenitally deaf.

According to the head of the study, Dr. Kazusaku Kamiya, this therapy could help not only cure deafness, but also eliminate other genetic diseases.

Hope for millions of people in the future

This breakthrough by Japanese scientists will allow millions of people to restore their hearing in the future. The scientific development is aimed at eliminating mutations in the human gene and may open the door to new opportunities in the field of medicine.

Gene therapy is one of the most promising areas in the field of human health, and its widespread use will help eliminate genetic diseases in the future. Follow “Zamin” news on “Telegram”